Table 1

Eligibility criteria

Inclusion criteriaExclusion criteria
Female patientsOral antibiotics/antifungal use in the previous 1 month to profiling stage*
Age ≥18 and ≤80Known diagnosis of diabetes or the use of anti-diabetic and/or weight-loss medication
Diagnosis of stage 1–3 HR+ breast cancer, who underwent surgeryBMI <18.5 kg/m2
At least 60 days after last non-endocrine oncology treatments (ie, definitive surgery, radiation or chemotherapy—whichever is last) if these were indicated.Patients under another diet regimen and/or a dietitian consultation/clinical study
Adjuvant endocrine therapy (either Tamoxifen or Aromatase inhibitor+/-GNRH agonists) taken for at least 30 days but no more than 24 months.Pregnancy, breast feeding
Willing to operate a smartphone applicationHIV carriers, cushing syndrome, chronic kidney disease, acromegaly, hyperthyroidism, liver cirrhosis
Known diagnosis of psychiatric disorders (schizophrenia, bipolar disorder)
Known diagnosis of (inflammatory bowel diseases)
Patients that underwent bariatric surgery
Known alcohol or substance abuse
  • *Patients will be offered to join the study at a later point.

  • BMI, body mass index.